Seres Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2024
Total Assets: $139.8M
Liabilities Breakdown FY2024
Total Liabilities: $126.0M
Asset Breakdown
Total Assets: $139.8M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $30.8M | 22.0% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $11.5M | 8.2% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $97.5M | 69.7% |
Liabilities Breakdown
Total Liabilities: $126.0M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $4.1M | 3.2% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $121.9M | 96.8% |